SCHOOL OF MEDICINE

Department of Medicine

Hematology/Oncology

Fellowship Program

Indiana University Hematology/Oncology Division Overview:

IU Simon Cancer Center - night view
Indiana University Health Simon Cancer Center
Walther Hall
Walther Hall
Canal Downtown from People Mover
Canal Downtown from People Mover
Cityview from R3
Cityview from R3
IUSCC from Student Center Roof top
IUSCC from Student Center
IUSCC Family Lounge
IUSCC Family Lounge

The Division of Hematology/Oncology at Indiana University is a part of the Indiana University Health Melvin and Bren Simon Cancer Center, established in 1992 as the IU Cancer Center, a National Cancer Institute (NCI)-designated Cancer Center since 1999, and the only center with such distinction in Indiana that provides patient care. The Division of Hematology Oncology is comprised of a diverse faculty including MD's, MD/PhD's and PhD's, with expertise in every major hematologic and oncology disease. The faculty has played a major role in establishing the standards for care in various malignancies including germ cell tumors, breast cancer, thymoma and lung cancer. Stem cell research is an area of particular strength in our program. The Division has a multi-disciplinary clinic in prostate cancer, lung cancer, breast cancer, gastro-intestinal tumors, head and neck cancer and melanoma.

In addition to their clinical expertise, IU faculty have been a part of serving as National and International leaders. For example, IU faculty have served as President of the American Society of Clinical Oncology (ASCO) [Dr. Lawrence Einhorn in 2000-2001 and Dr. George Sledge in 2010-2011]. Hal Broxmeyer, Ph.D., is a past President of the American Society of Hematology (ASH). Several other faculty members and former fellows have served in other leadership capacity, including on the Board of Directors for ASCO, members of the Oncology Drug Advisory Committee (ODAC) to the FDA, and served as Editors of major oncology journals including the Journal of Clinical Oncology (JCO). Excellent mentoring opportunities over the years have assisted many IU Hematology/Oncology Fellowship graduates in becoming National and International leaders in their respective fields.

Dr.Nelson and team

The Division of Hematology/Oncology at Indiana University offers a combined three year program. Fellows are offered the opportunity to be eligible for board certification in both disciplines of Hematology and Medical Oncology. Fellows also have the option of pursuing a two year program in one of the two sub-specialties. The number of fellows in our combined program is variable, based upon individual research interests of senior fellows. In general, 15 fellowship positions are available. Our Program has received the highest level of accreditation by the ACGME with a maximum cycle length of 5 years.

During the period from 2013 to 2015, 100% of our fellows who were eligible for and elected to take ABIM certifying exams in Hematology and Medical Oncology received passing scores.

Michael J. Robertson, M.D.
Professor of Medicine
Director, Lymphoma Program
Director, Adult Hematology/Oncology Fellowship Program
☎ : (317) 948-6942
Fax: (317) 948-9302

Address for Fellowship Program Office:
Indiana University
Department of Hematology Oncology, Fellowship Program
535 Barnhill Drive, RT 473, Indianapolis, IN 46202
☎ : (317) 948-6942
Fax: (317) 948-9302

Our program is customizable to meet the career goals of our fellows. We devote a major teaching effort during the three-year program to maximize the likelihood that our trainees will have all requisite skills to compete successfully for research funding in academia and to be optimally prepared for careers in academic medicine as teacher- investigators. We also prepare our fellows to be successful for a career in general hematology/oncology in a private practice setting.

Hematology/Oncology Program Collage

Strengths of the fellowship Program:

  • Excellent clinical training
  • Great mentoring
  • 100% board pass rate
  • Ability to customize your fellowship experience to meet your personal educational goals
  • Located in the heart of Indianapolis (a great place to live)

 

 

The program is designed to meet the individual needs and interest of each fellow. The typical first year is a clinical year with rotations through the various clinical services, including in-patient hematology, oncology, bone marrow transplantation, and consult services in hematology and oncology at University Hospital, Eskenazi Health (the county hospital serving the city of Indianapolis) and the VA Medical Center. Patient care activities at Indiana University take place at the Indiana University Health Simon Cancer Center, a state-of-the art cancer hospital, which opened in 2010, or at the adjacent University Hospital.

The second and third years of the program allow for fellows to complete additional clinical rotations, but the focus of these years is primarily on gaining research experience. Fellows are assigned an adviser during their first year and a formal mentor during their second and third year of fellowship. First and second years will meet with a mentoring committee throughout the year. Major blocks of time are designated for laboratory or clinical research; these academic and scholarly activities are an integral part of our training program. It is expected that, during these years, each fellow will accomplish sufficient clinical or basic science research of high quality so that at least one presentation for a national meeting and a peer review publication will be possible. National meetings include ASCO, AACR, and ASH.Guidance and mentoring is supplied by our faculty.

Examples of our current fellows' research projects can be found here . In addition, there are opportunities for individual fellows to obtain specialty training in palliative medicine, geriatrics, ethics, pharmacology, and public health.

Lacey Dobrolecki, research

technician, in the lab

The specific laboratory and clinical research activities of the Division are numerous. Our fellows have achieved success in contributing to our understanding and management of cancer. Every fellow is expected to engage in a mentored research project during their fellowship. Active research programs exist in tumor biology, hematopoiesis, signal transduction, pharmacogenomics, and molecular biology. A new research facility houses the Walther Cancer Institute and is directed by Hal Broxmeyer, Ph.D. The Division belongs to a number of cooperative research groups including the Eastern Cooperative Oncology Group, the Gynecological Oncology Group, the Radiation Therapy Oncology Group, Hoosier Cancer Research Network, the Children’s Cancer Study Group, and the Children’s Oncology Group. Of particular interest is the 31 year history of Indiana University’s role as the academic foundation for the Hoosier Oncology Group, a community-based oncology group founded in 1984. This group provides an excellent opportunity for our fellows to gain experience in clinical trial design, including protocol writing and presentation of HOG data at national meetings.

Dr. Schneider in Lab

Each fellow will have a continuity-of-care clinic throughout their 3 year fellowship. This includes a hematology clinic at the VA Medical Center or Eskenazi Health, as well as an oncology clinic at the VA Medical Center or Eskenazi Health. In addition, each fellow will have rotating 3-month sub-specialty clinics throughout their 3 years. Sub-specialty care includes multi-disciplinary care clinics for breast, thoracic, gastrointestinal, genitourinary cancers as well as leukemia, lymphoma and benign hematology, including experience at the Indiana Hemophilia and Thrombosis Center. Additional clinics are available and include sarcoma, renal cancer, melanoma, head/neck cancer, myeloma, bone marrow transplantation, gynecological cancer, testicular cancer, and radiation oncology.While on the in-patient services and consult services at IU, Eskenazi, or the VA, the fellow plays a prominent role as the junior attending, supervised by a faculty member.

Multi-disciplinary care is carried out through our very close ties with other sections and departments.  Specifically, Indiana University Hospital has a well-equipped Department of Radiation Oncology. The Department of Urology is noted internationally for its excellent surgical treatment of urologic cancer, in particular testicular cancer.  The Department of Thoracic surgery is renowned for their treatment of lung, esophageal, thymic, and mediastinal cancers.  Likewise, there is a close relationship between our Division and the Department of Pathology, Orthopedics Oncology, Pediatric Hematology/Oncology, Surgery, and various subspecialties, and the Central Indiana Regional Blood Center.

Additional clinics are available and include sarcoma, renal cancer, melanoma, head/neck cancer, myeloma, bone marrow transplantation,gynecological cancer, testicular cancer, and radiation oncology.

Formal conferences are considered to be a central part of the fellow’s education. Each subspecialty has a weekly multi-disciplinary conference. Weekly conferences in both hematology and oncology are organized by the fellows and supervised by the faculty. A monthly Journal Club enhances the fellows’ ability to critique relevant articles from the current literature. In addition, all lectures, faculty and fellow presentations and journal club reviews are stored on the Hematology/Oncology site of Oncourse, the learning center for Indiana University School of Medicine.

 

Bottom Row, Left to Right: Marwan Mounayar, MD, Neda Hashemi, MD, Laura Lourdes, MD, Jill Kremer, MD, Maitri Kalra, MD, Tarah Ballinger, MD, Hirva Mamdani, MD * (Chief Fellow)
Top Row, Left to Right: Adam Miller, MD, Nabil Adra, MD, Anthony Betbadal, MD, Derek Thomas, MD, Nabin Khanal, MD, Alvaro Gerardo Menendez, MD, Shahid Ahmed, MD, Olumide Gbolahan, MD

Indy Monument Circle

Information about Indianapolis area